Park YY - Search Results

1

AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway.

Pokhrel RH, Acharya S, Ahn JH, Gu Y, Pandit M, Kim JO, Park YY, Kang B, Ko HJ, Chang JH. Pokhrel RH, et al. Among authors: park yy. Mol Cancer. 2021 Oct 14;20(1):133. doi: 10.1186/s12943-021-01420-9. Mol Cancer. 2021. PMID: 34649584 Free PMC article.

2

Activation of Mevalonate Pathway via LKB1 Is Essential for Stability of T_reg Cells.

Timilshina M, You Z, Lacher SM, Acharya S, Jiang L, Kang Y, Kim JA, Chang HW, Kim KJ, Park B, Song JH, Ko HJ, Park YY, Ma MJ, Nepal MR, Jeong TC, Chung Y, Waisman A, Chang JH. Timilshina M, et al. Among authors: park yy, park b. Cell Rep. 2019 Jun 4;27(10):2948-2961.e7. doi: 10.1016/j.celrep.2019.05.020. Cell Rep. 2019. PMID: 31167140 Free article.

3

ERdj5 protects goblet cells from endoplasmic reticulum stress-mediated apoptosis under inflammatory conditions.

Jeong H, Hong EH, Ahn JH, Cho J, Jeong JH, Kim CW, Yoon BI, Koo JH, Park YY, Yang YM, Iwawaki T, Vallance BA, Chang SY, Ko HJ. Jeong H, et al. Among authors: park yy. Exp Mol Med. 2023 Feb;55(2):401-412. doi: 10.1038/s12276-023-00945-x. Epub 2023 Feb 9. Exp Mol Med. 2023. PMID: 36759578 Free PMC article.

4

AMPK-HIF-1α signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth.

Yun HJ, Li M, Guo D, Jeon SM, Park SH, Lim JS, Lee SB, Liu R, Du L, Kim SH, Shin TH, Eyun SI, Park YY, Lu Z, Lee JH. Yun HJ, et al. Among authors: park yy. J Exp Clin Cancer Res. 2023 Dec 15;42(1):340. doi: 10.1186/s13046-023-02927-3. J Exp Clin Cancer Res. 2023. PMID: 38098117 Free PMC article.

5

Relief of YAP-mediated inhibition by IKKɛ promotes innate antiviral immunity.

Kim N, Park YY, Joo CH, Kim HS. Kim N, et al. Among authors: park yy. Cell Mol Immunol. 2018 Jun;15(6):642-644. doi: 10.1038/cmi.2017.97. Epub 2017 Oct 23. Cell Mol Immunol. 2018. PMID: 29057972 Free PMC article. No abstract available.

6

ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors.

Shin SH, Ju EJ, Park J, Ko EJ, Kwon MR, Lee HW, Son GW, Park YY, Kim YJ, Song SY, Lee S, Seo BS, Song JA, Lim S, Jung D, Kim S, Lee H, Park SS, Jeong SY, Choi EK. Shin SH, et al. Among authors: park yy. Cancer Cell Int. 2023 Aug 18;23(1):172. doi: 10.1186/s12935-023-02991-x. Cancer Cell Int. 2023. PMID: 37596639 Free PMC article.

7

Genomic analysis of nuclear receptors and miRNAs identifies a role for the NR3C1/miR-200 axis in colon cancer.

Park YY. Park YY. Genes Genomics. 2021 Aug;43(8):913-920. doi: 10.1007/s13258-021-01112-0. Epub 2021 May 22. Genes Genomics. 2021. PMID: 34021858

8

Phosphofructokinase 1 platelet isoform induces PD-L1 expression to promote glioblastoma immune evasion.

Wang S, Park SH, Lim JS, Park YY, Du L, Lee JH. Wang S, et al. Among authors: park yy, park sh. Genes Genomics. 2022 Dec;44(12):1509-1517. doi: 10.1007/s13258-022-01291-4. Epub 2022 Aug 2. Genes Genomics. 2022. PMID: 35917090

9

Mutual regulation between phosphofructokinase 1 platelet isoform and VEGF promotes glioblastoma tumor growth.

Lim JS, Shi Y, Park SH, Jeon SM, Zhang C, Park YY, Liu R, Li J, Cho WS, Du L, Lee JH. Lim JS, et al. Among authors: park yy, park sh. Cell Death Dis. 2022 Nov 26;13(11):1002. doi: 10.1038/s41419-022-05449-6. Cell Death Dis. 2022. PMID: 36435833 Free PMC article.

10

Correction to: Genomic analysis of nuclear receptors and miRNAs identifies a role for the NR3C1/miR-200 axis in colon cancer.

Park YY. Park YY. Genes Genomics. 2021 Aug;43(8):921. doi: 10.1007/s13258-021-01132-w. Epub 2021 Jul 14. Genes Genomics. 2021. PMID: 34260045 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

225 results

Search Page